THE MDPHP DIARIES

MDPHP is assumed to act mostly for a strong norepinephrine-dopamine reuptake inhibitor (NDRI). Lessened re-uptake of norepinephrine and dopamine ends in increased concentrations of The 2 catecholamine neurotransmitters inside the synaptic cleft, or gap amongst neurons. The results of this inhibition is undoubtedly an enhanced and prolonged focus an